• Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    2 1
    Austria Belgium Bulgaria Croatia Czechia Denmark +13

  • Study of Long-term Safety of Tazemetostat in Patients Who Previously Participated in Tazemetostat Clinical Trials

    Not recruiting

    1 1 1
    Investigated diseases:
    France Poland

  • Study on Intravenous Ferric Carboxymaltose for Preoperative Anemia in Patients with Lower Limb Peripheral Artery Disease

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Spain

  • A Study of GEN1047 in Patients with Solid Tumors: First Time Use in Humans

    Not recruiting

    2 1 1
    Investigated diseases:
    Belgium Denmark France Italy The Netherlands Poland +1

  • Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

    Not recruiting

    3 1 1
    Investigated diseases:
    Belgium Bulgaria Czechia Denmark France Germany +9

  • Study of Durvalumab in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Belgium

  • Study on the Safety and Effects of YTB323, Fludarabine Phosphate, and Tocilizumab in Patients with Severe, Refractory Systemic Lupus Erythematosus

    Not recruiting

    1 1 1 1
    Investigated diseases:
    France Germany Spain

  • Study on the Effects of INT-787 for Patients with Severe Alcohol-Associated Hepatitis

    Not recruiting

    2 1
    Investigated diseases:
    France

  • Study of Imetelstat in Patients with Low or Intermediate Risk Myelodysplastic Syndromes (MDS) Refractory to Erythropoiesis-Stimulating Agents

    Not recruiting

    4 1 1
    Belgium Czechia France Germany Italy The Netherlands +2

  • Study on Fipaxalparant for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated diseases:
    France Greece Italy The Netherlands Poland Spain

powered by